Correspondence re: C. Chen, K. E. Malone, J. Prunty, and J. R. Daling, measurement of urinary estrogen metabolites using a monoclonal enzyme-linked immunoassay kit: assay performance and feasibility for epidemiological studies

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 2, 1997, Pages 145-147

  Bradlow, H Leon ^a,b   Sepkovic, Daniel W ^a   Telang, Nilin T ^a  

^a Strang Cancer Research Laboratory   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTROGEN URINE LEVEL; HUMAN; LETTER; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTROGENS; HUMANS;

EID: 0031024365     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Chen, C., Malone, K. E., Prunty, J., and Daling, J. R. Measurement of urinary estrogen metabolites using a monoclonal enzyme-linked immunoassay kit: assay performance and feasibility for epidemiological studies. Cancer Epidemiol, Biomarkers and Prevention. 5: 727-732, 1996.
2. Sepkovic, D. W., Bradlow, H. L., Ho, O., Hankinson, S. E., Gong, L., Osborne, M. P., and Fishman, J. Estrogen metabolite ratios and risk assessment of hormone-related cancers: assay validation and prediction of cervical cancer risk. In: H. L. Bradlow, M. P. Osborne, and U. Veronesi (eds.). Cancer Prevention: From the Laboratory to the Clinic, Implications of Genetic, Molecular, and Preventive Research, Vol. 768, pp. 312-316. New York: New York Academy of Sciences, 1996.
3. Pasagian-Macauley, A., Meilahn, E. N., Bradlow, H. L., Sepkovic, D. W., Buhari, A. M., Simlin-Silverman, L., Wing, R. R., and Kuller, L. H. Urinary markers of estrogen metabolism 2- and 16α-hydroxylation in premenopausal women. Steroids, 61: 461-467, 1996.